TNFSF13B and atherosclerosis: (271)demonstrated that in ApoE-/- and Ldlr-/- mice, treatment with BAFF-neutralizing antibodies induced features of advanced atherosclerosis, including elevated levels of pro-inflammatory factors KC and MCP-1.